{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:19:50Z","timestamp":1787523590643,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Isr J Health Policy Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-market surveillance systems are essential for identifying medical device\u2013related adverse events and ensuring patient safety. In Israel, the Ministry of Health has operated a national medical device reporting system for decades. The system is modeled on United States and European regulatory frameworks, although the Medical Devices Act has not yet entered into force.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following formal approval, anonymized aggregate data were obtained from the Ministry of Health Medical Device Division for reports submitted between 2013 and 2024. The dataset included annual reporting volumes, report classification as adverse events or Field Safety Notices, reporting source, and event type (death, injury, or malfunction), where available. Availability varied across the study period; analyses were therefore restricted to years in which the relevant variables were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall reporting volumes increased over time, from 406 in 2013 to 874 in 2024. Non-linear trends were observed, with declines in 2017, 2020, 2022, and 2024. Since 2019, adverse events accounted for approximately 61.9\u201375.5% of reports annually, while Field Safety Notices comprised 21.4\u201333.3%. From 2022 onward, most adverse events were classified as injuries, increasing from 87.1% in 2022 to 89.8% in 2023 and remaining high at 89.1% in 2024. Malfunctions accounted for 10.3% of adverse events in 2022, 7.9% in 2023, and 8.5% in 2024, whereas deaths remained relatively stable at 2.2\u20132.5%. Reporting was dominated by registration holders (70\u201380%), primarily importers and distributors, followed by manufacturers, with consistently limited contributions from healthcare institutions and voluntary reporters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This analysis of Israel\u2019s national medical device reporting database provides an empirical baseline for assessing the structure and functioning of the country\u2019s post-market surveillance system. Increasing reporting activity and improved event classification indicate system maturation. The predominance of reports from registration holders, alongside more limited participation by healthcare institutions and voluntary reporters, points to areas for continued development. The following measures would strengthen post-market surveillance in Israel: full implementation of the legal framework; clearer reporting responsibilities and pathways: targeted guidance and training; electronic reporting and analytical tools; improved event documentation; and structured feedback and transparency mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13584-026-00776-x","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:01:46Z","timestamp":1787522506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["National adverse event reporting for medical devices in Israel, 2013\u20132024"],"prefix":"10.1186","volume":"15","author":[{"given":"Meital","family":"Mishali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Sheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Negev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"776_CR1","doi-asserted-by":"publisher","unstructured":"Hinrichs-Krapels S, Ditewig B, Boulding H, Chalkidou A, Erskine J, Shokraneh F. Purchasing high-cost medical devices and equipment in hospitals: A systematic review. BMJ Open. 2022;12(9) :e057516. https:\/\/doi.org\/10.1136\/bmjopen-2021-057516","DOI":"10.1136\/bmjopen-2021-057516"},{"issue":"2","key":"776_CR2","doi-asserted-by":"publisher","first-page":"e027041","DOI":"10.1136\/bmjopen-2018-027041","volume":"9","author":"S Sauerland","year":"2019","unstructured":"Sauerland S, Fujita-Rohwerder N, Zens YMS. Premarket evaluation of medical devices: a cross-sectional analysis of clinical studies submitted to a German ethics committee. BMJ Open. 2019;9(2):e027041.","journal-title":"BMJ Open"},{"issue":"6","key":"776_CR3","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3233\/THC-220284","volume":"30","author":"A Badnjevi\u0107","year":"2022","unstructured":"Badnjevi\u0107 A, Pokvi\u0107 LG. Amar Deumi\u0107 and LSB. Post-market surveillance of medical devices: a review. Technol Heal Care. 2022;30(6):1315\u201329.","journal-title":"Technol Heal Care"},{"key":"776_CR4","unstructured":"FDA. Medical Device Reporting (MDR). US. 2025 p. 64\u201381."},{"key":"776_CR5","unstructured":"FDA. MAUDE - Manufacturer and User Facility Device Experience."},{"key":"776_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/PROM.S212991","volume":"10","author":"KT Kavanagh","year":"2019","unstructured":"Kavanagh KT, Brown RE Jr, Kraman SS, Calderon LE, Kavanagh SP. Reporter\u2019s occupation and source of adverse device event reports contained in the FDA\u2019s MAUDE database. Patient Relat Outcome Meas. 2019;10:205\u20138.","journal-title":"Patient Relat Outcome Meas"},{"key":"776_CR7","first-page":"205520762513140","volume":"11","author":"M Mishali","year":"2025","unstructured":"Mishali M, Sheffer N, Mishali O, Negev M. Evaluation of reporting trends in the MAUDE Database: 1991 to 2022. Digit Heal. 2025;11:20552076251314096.","journal-title":"Digit Heal"},{"key":"776_CR8","unstructured":"European Union. REGULATION (EU) 2017\/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. 2017."},{"issue":"2","key":"776_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.25259\/IJMR_86_2025","volume":"162","author":"M Manimuthukumar, Oviyaasri","year":"2025","unstructured":"Manimuthukumar, Oviyaasri M, Manjuladevi. Global trends in post-market surveillance of high-risk medical devices: An empirical analysis based on regulatory data. Indian J Med Res. 2025;162(2):163.","journal-title":"Indian J Med Res"},{"issue":"1","key":"776_CR10","first-page":"56","volume":"3","author":"A Craig","year":"2019","unstructured":"Craig A, Meley PO, Carter P. The need for greater reporting of medical device incidents. Eur Med J. 2019;3(1):56\u201363.","journal-title":"Eur Med J"},{"issue":"10","key":"776_CR11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMp1114865","volume":"366","author":"FS Resnic","year":"2012","unstructured":"Resnic FS. Postmarketing surveillance of medical devices - Filling in the gaps. N Engl J Med. 2012;366(10):875\u20137.","journal-title":"N Engl J Med"},{"issue":"2","key":"776_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40801-018-0134-0","volume":"5","author":"T Toki","year":"2018","unstructured":"Toki T, Ono S. Spontaneous reporting on adverse events by consumers in the United States: An analysis of the Food and Drug Administration Adverse Event Reporting System database. Drugs - Real World Outcomes. 2018;5(2):117\u201328.","journal-title":"Drugs - Real World Outcomes"},{"key":"776_CR13","unstructured":"Ministry of Health. Medical Device Act [Internet]. Israel. 2012. Available from: https:\/\/www.health.gov.il\/LegislationLibrary\/Briut50.pdf"},{"key":"776_CR14","unstructured":"Ministry of Health. Medical Administration Circular No. 2\/2021: Mandatory Reporting of Adverse or Unusual Events by Healthcare Institutions [Internet]. 2021. Available from: https:\/\/www.gov.il\/he\/pages\/mr02-2021"},{"issue":"7","key":"776_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s40264-017-0534-1","volume":"40","author":"M Banovac","year":"2017","unstructured":"Banovac M, Candore G, Slattery J, Hou\u00ffez F, Haerry D, Genov G, et al. Patient reporting in the EU: Analysis of EudraVigilance data. Drug Saf. 2017;40(7):629\u201345.","journal-title":"Drug Saf"},{"issue":"2","key":"776_CR16","first-page":"123","volume":"32","author":"Y Inokuma","year":"2018","unstructured":"Inokuma Y, Sato Y, Masuda S. Adverse Event reporting patterns of marketing authorization holders, healthcare professionals and patients in Japan: Lessons learnt from the human papilloma virus vaccine. Pharmaceut Med. 2018;32(2):123\u20139.","journal-title":"Pharmaceut Med"},{"issue":"5","key":"776_CR17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/hpm.3654","volume":"38","author":"I Reychav","year":"2023","unstructured":"Reychav I, Yaakobi A, Mchaney R, Tal Y, Manor O. Identification of behavioural changes in reporting adverse events early during COVID-19: An ambulatory care perspective in Israel. Int J Heal Plann Mgmt. 2023;38(5):1314\u201329.","journal-title":"Int J Heal Plann Mgmt"},{"issue":"3","key":"776_CR18","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.3390\/ijerph19031592","volume":"19","author":"R Su","year":"2022","unstructured":"Su R, Obrenovic B, Du J, Godinic D. COVID-19 pandemic implications for corporate sustainability and society: A literature review. Int J Environ Res Public Health. 2022;19(3):1592.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"776_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1377\/hlthaff.2020.00980","volume":"39","author":"JD Birkmeyer","year":"2020","unstructured":"Birkmeyer JD, Barnato A, Birkmeyer N, Bessler R. The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Aff. 2020;39(11):10\u20131.","journal-title":"Health Aff"},{"key":"776_CR20","unstructured":"Sagan A, Webb E, McKee M, Greer SL, Karanikolos M, Williams GA, et al. Health systems resilience during COVID-19: Lessons for building back better. Sagan, Anna, Erin Webb, Natasha Azzopardi-Muscat, Isabel de la Mata Martin McKee JF. editor. World health organization; 2021. pp. 1\u2013108."},{"issue":"3","key":"776_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/SLA.0b013e318199f232","volume":"249","author":"A Hadary","year":"2009","unstructured":"Hadary A, Schecter W, Embon OM. Impact of military conflict on a civilian receiving hospital in a war zone. Ann Surg. 2009;249(3):502\u20139.","journal-title":"Ann Surg"},{"issue":"1","key":"776_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clinthera.2024.10.004","volume":"47","author":"M Mishali","year":"2025","unstructured":"Mishali M, Sheffer N, Mishali O, Negev M. Understanding variation among medical device reporting sources: A study of the MAUDE database. Clin Ther. 2025;47(1):76\u201381.","journal-title":"Clin Ther"},{"key":"776_CR23","doi-asserted-by":"publisher","first-page":"1720494","DOI":"10.3389\/frhs.2025.1720494","volume":"5","author":"M Mishali","year":"2025","unstructured":"Mishali M, Sheffer N. Challenges and Dynamics in Reporting Medical Device Incidents: A Qualitative Study. Front Heal Serv. 2025;5:1720494.","journal-title":"Front Heal Serv"},{"issue":"1","key":"776_CR24","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1186\/s12913-024-11885-1","volume":"24","author":"S Choi","year":"2024","unstructured":"Choi S, Jeong S, Choi S, Park KC, Nam HJ, Jang JK, Kim YK, Lee. Hiroshi Ishikawa and EW. The application study of harmonization code in medical device adverse event reporting. BMC Health Serv Res. 2024;24(1):1402.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"776_CR25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3233\/THC-220284","volume":"30","author":"A Badnjevi\u0107","year":"2022","unstructured":"Badnjevi\u0107 A, Pokvi\u0107 LG, Deumi\u0107 A, Be\u0107irovi\u0107 LS. Post-market surveillance of medical devices: A review. Technol Heal Care. 2022;30(6):1315\u201329.","journal-title":"Technol Heal Care"},{"issue":"1","key":"776_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12911-024-02659-0","volume":"24","author":"A Hochreiter-Hufford","year":"2024","unstructured":"Hochreiter-Hufford A, Gatz J, Griggs AM, Schoch RD, Birmingham KM, Frederick C, Price J. Real-world data to support post-market safety and performance of embolization coils: evidence generation from a medical device manufacturer and data institute partnership. BMC Med Inf Decis Mak. 2024;24(1):263.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"776_CR27","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1186\/s12913-022-08830-5","volume":"22","author":"J Sun","year":"2022","unstructured":"Sun J, Pan J, Jin Y, Zhang Q, Lv Y. Establishment of a medical device adverse event management system for hospitals. BMC Health Serv Res. 2022;22(1):1406.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"776_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.sapharm.2018.07.015","volume":"15","author":"P Aslani","year":"2019","unstructured":"Aslani P, Hamrosi K, Tong V, Chen TF, Cook J, Fois R, McGarry T, Moore C, Peters R, Spagnardi S, Whitelock K. Consumer opinions on adverse events associated with medical devices. Res Soc Adm Pharm. 2019;15(5):568\u201374.","journal-title":"Res Soc Adm Pharm"},{"issue":"10","key":"776_CR29","doi-asserted-by":"publisher","first-page":"e0224233","DOI":"10.1371\/journal.pone.0224233","volume":"14","author":"F Alsohime","year":"2019","unstructured":"Alsohime F, Temsah M-H, Hasan G, Al-Eyadhy A, Gulman S. Haytam Issa and OA. Reporting adverse events related to medical devices: A single center experience from a tertiary academic hospital. PLoS ONE. 2019;14(10):e0224233.","journal-title":"PLoS ONE"},{"key":"776_CR30","unstructured":"FDA (Food and Drug Administration). Reporting Serious Problems to FDA- MedWatch [Internet]. 2025. Available from: https:\/\/www.fda.gov\/safety\/medwatch-fda-safety-information-and-adverse-event-reporting-program\/reporting-serious-problems-fda?utm_source=chatgpt.com"},{"key":"776_CR31","unstructured":"UNION TEPATCOTE. REGULATION (EU) 2017\/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION [Internet]. 2017;L 117:1\u2013175. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32017R0745"}],"container-title":["Israel Journal of Health Policy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-026-00776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13584-026-00776-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13584-026-00776-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T22:01:48Z","timestamp":1787522508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13584-026-00776-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1186\/s13584-026-00776-x","relation":{},"ISSN":["2045-4015"],"issn-type":[{"value":"2045-4015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"32"}}